SCHEMBL15086777

SCHEMBL15086777

COc1ccc(-c2ccn(C(=O)c3cccc(F)c3)n2)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 5/20 0.51
▸ SCN4A P35499 1/20 0.46
▸ RELA Q04206 1/20 0.46
▸ MAPT P10636 2/20 0.45
▸ S1PR1 P21453 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ KLK3 P07288 2/20 0.43
▸ SCD O00767 1/20 0.43
▸ SCD5 Q86SK9 1/20 0.43
▸ CYP1A2 P05177 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ ATR Q13535 1/20 0.42
▸ F2 P00734 1/20 0.42
▸ PLAU P00749 1/20 0.42
▸ KLKB1 P03952 1/20 0.42
▸ ELANE P08246 1/20 0.42
▸ SIRT5 Q9NXA8 1/20 0.42
▸ LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4491543 0.78 FYN (0.49) FYNSCN4AMAPTKMT2AALDH1A1
SCHEMBL15086782 0.77 SMN1; SMN2 (0.51) FYNMAPTKMT2AALDH1A1LMNA
SCHEMBL15086702 0.73 MAOB (0.64) MAPTS1PR1KMT2AALDH1A1SCD
SCHEMBL2390999 0.73 FYN (0.45) FYNSCN4AMAPTKMT2AALDH1A1
SCHEMBL6232769 0.73 SCN4A (0.49) FYNSCN4AKMT2APIK3CAATR
SCHEMBL14484304 0.73 ALDH1A1 (0.44) RELAMAPTS1PR1KMT2AALDH1A1
SCHEMBL14484779 0.73 PDE4B (0.48) RELAMAPTS1PR1KMT2AALDH1A1
SCHEMBL4183271 0.72 CFTR (0.47) FYNMAPTKMT2APIK3CAATR
SCHEMBL15086749 0.69 SCD (0.49) KMT2AALDH1A1SCDSCD5
SCHEMBL10436281 0.68 KIT (0.59) FYNRELAKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170368030-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-12-28 — — US disclosed
US-9775830-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-10-03 — — US disclosed
US-9775830-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-10-03 — — US disclosed
US-20170071910-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-03-16 — — US disclosed
US-20170071910-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2017-03-16 — — US disclosed
US-9517227-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2016-12-13 — — US disclosed
US-9517227-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2016-12-13 — — US disclosed
US-20140296238-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-10-02 — — US disclosed
US-20140296238-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-10-02 — — US disclosed
US-8791114-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-07-29 — — US disclosed
US-8791114-B2 Dihydropyrazoles MERCK PATENT GMBH (DE) 2014-07-29 — — US disclosed
US-20130172351-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2013-07-04 — — US disclosed
US-20130172351-A1 Dihydropyrazoles MERCK PATENT GMBH (DE) 2013-07-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170368030-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR FYN 1460/4885SCN4A 625/4885RELA 2756/4885
US-20130172351-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR FYN 1460/4885SCN4A 625/4885RELA 2756/4885
US-20140296238-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR FYN 1460/4885SCN4A 625/4885RELA 2756/4885
US-20170071910-A1 Dihydropyrazoles FSHR, GNRHR, LHCGR FYN 1460/4885SCN4A 625/4885RELA 2756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback